116 related articles for article (PubMed ID: 17523009)
1. Transport of insulin in modified Valia-Chien chambers and Caco-2 cell monolayers.
Tang C; Yu J; Yin L; Yin C; Pei Y
Drug Dev Ind Pharm; 2007 Apr; 33(4):449-56. PubMed ID: 17523009
[TBL] [Abstract][Full Text] [Related]
2. SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats.
Liu J; Werner U; Funke M; Besenius M; Saaby L; Fanø M; Mu H; Müllertz A
Int J Pharm; 2019 Apr; 560():377-384. PubMed ID: 30790612
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Caco-2 monolayer as a model epithelium for iontophoretic transport.
Leonard M; Creed E; Brayden D; Baird AW
Pharm Res; 2000 Oct; 17(10):1181-8. PubMed ID: 11145222
[TBL] [Abstract][Full Text] [Related]
4. Oligonucleotide transport in rat and human intestine ussing chamber models.
Wu-Pong S; Livesay V; Dvorchik B; Barr WH
Biopharm Drug Dispos; 1999 Dec; 20(9):411-6. PubMed ID: 10951429
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of intestinal absorption of macromolecules by spermine in rats.
Sugita Y; Takao K; Toyama Y; Shirahata A
Amino Acids; 2007 Aug; 33(2):253-60. PubMed ID: 17653818
[TBL] [Abstract][Full Text] [Related]
6. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy.
Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
J Pharm Sci; 1997 Jul; 86(7):779-85. PubMed ID: 9232516
[TBL] [Abstract][Full Text] [Related]
7. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.
Hurni MA; Noach AB; Blom-Roosemalen MC; de Boer AG; Nagelkerke JF; Breimer DD
J Pharmacol Exp Ther; 1993 Nov; 267(2):942-50. PubMed ID: 7504101
[TBL] [Abstract][Full Text] [Related]
8. Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells.
Mao S; Germershaus O; Fischer D; Linn T; Schnepf R; Kissel T
Pharm Res; 2005 Dec; 22(12):2058-68. PubMed ID: 16170693
[TBL] [Abstract][Full Text] [Related]
9. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers?
Behrens I; Kissel T
Eur J Pharm Sci; 2003 Aug; 19(5):433-42. PubMed ID: 12907294
[TBL] [Abstract][Full Text] [Related]
10. A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine.
Gupta V; Hwang BH; Doshi N; Mitragotri S
J Control Release; 2013 Dec; 172(2):541-9. PubMed ID: 23680288
[TBL] [Abstract][Full Text] [Related]
11. Fluorescein transport properties across artificial lipid membranes, Caco-2 cell monolayers and rat jejunum.
Berginc K; Zakelj S; Levstik L; Ursic D; Kristl A
Eur J Pharm Biopharm; 2007 May; 66(2):281-5. PubMed ID: 17129714
[TBL] [Abstract][Full Text] [Related]
12. Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer.
Kavimandan NJ; Peppas NA
Int J Pharm; 2008 Apr; 354(1-2):143-8. PubMed ID: 18262739
[TBL] [Abstract][Full Text] [Related]
13. Impact of Lipid-Based Drug Delivery Systems on the Transport and Uptake of Insulin Across Caco-2 Cell Monolayers.
Li P; Nielsen HM; Müllertz A
J Pharm Sci; 2016 Sep; 105(9):2743-2751. PubMed ID: 26921121
[TBL] [Abstract][Full Text] [Related]
14. Role of the mucous/glycocalyx layers in insulin permeation across the rat ileal membrane.
Aoki Y; Morishita M; Takayama K
Int J Pharm; 2005 Jun; 297(1-2):98-109. PubMed ID: 15907598
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
[TBL] [Abstract][Full Text] [Related]
16. Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs.
Sha X; Fang X
Int J Pharm; 2004 Mar; 272(1-2):161-71. PubMed ID: 15019079
[TBL] [Abstract][Full Text] [Related]
17. Use of simulated intestinal fluids with Caco-2 cells and rat ileum.
Patel N; Forbes B; Eskola S; Murray J
Drug Dev Ind Pharm; 2006 Feb; 32(2):151-61. PubMed ID: 16537196
[TBL] [Abstract][Full Text] [Related]
18. Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: assessment of molecular weight dependence and demonstration of transport routes.
Lindmark T; Schipper N; Lazorová L; de Boer AG; Artursson P
J Drug Target; 1998; 5(3):215-23. PubMed ID: 9606011
[TBL] [Abstract][Full Text] [Related]
19. Multiple pathways are involved in the oral absorption of BMS-262084, a tryptase inhibitor, in rats: role of paracellular transport, binding to trypsin, and P-glycoprotein efflux.
Kamath AV; Morrison RA; Harper TW; Lan SJ; Marino AM; Chong S
J Pharm Sci; 2005 May; 94(5):1115-23. PubMed ID: 15793809
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
